Malaria | DISEASE

French First Lady Carla Bruni-Sarkozy, second left, Bill Gates spouse Melinda, third right sitting, and executive director of the U.N.-backed Global Fund to Fight AIDS Michel Kazatchkine, the hospital "Auberge de l'Amour Redempteur" , Wednesday Jan. 27, 2010 in Dangbo, Benin. Carla Bruni-Sarkozy started Tuesday a two-day visit to Benin as ambassador of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Benin's President Thomas Boni Yayi, foreground right, French First Lady Carla Bruni-Sarkozy, left, and Michel Kazatchkine, executive director of the U.N.-backed Global Fund to Fight AIDS, center, seen upon their arrival at the presidential palace in Cotonou, Tuesday, Jan. 26, 2010. Carla Bruni-Sarkozy started Tuesday a two-day visit to Benin as ambassador of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Benin's President Thomas Boni Yayi, right, French first lady Carla Bruni-Sarkozy and Michel Kazatchkine, executive director of the U.N.-backed Global Fund to Fight AIDS, seen upon their arrival at the presidential palace in Cotonou, Benin, Tuesday, Jan. 26, 2010. Carla Bruni-Sarkozy started Tuesday a two-day visit to Benin as ambassador of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

French First Lady Carla Bruni-Sarkozy, center, and Michel Kazatchkine, executive director of the U.N.-backed Global Fund to Fight AIDS, right, leave following their meeting with Benin's President Thomas Boni Yayi at the presidential palace in Cotonou, Tuesday, Jan. 26, 2010. Carla Bruni-Sarkozy started Tuesday a two-day visit to Benin as ambassador of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Benin's President Thomas Boni Yayi, right, and French First Lady Carla Bruni-Sarkozy meet at the presidential palace in Cotonou, Tuesday, Jan. 26, 2010. Carla Bruni-Sarkozy started Tuesday a two-day visit to Benin as ambassador of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Benin's President Thomas Boni Yayi, right, and French First Lady Carla Bruni-Sarkozy meet at the presidential palace in Cotonou, Tuesday, Jan. 26, 2010. Carla Bruni-Sarkozy started Tuesday a two-day visit to Benin as ambassador of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

French First Lady Carla Bruni-Sarkozy, center, and Michel Kazatchkine, executive director of the U.N.-backed Global Fund to Fight AIDS, right, answer reporters following their meeting with Benin's President Thomas Boni Yayi, unseen, at the presidential palace in Cotonou, Tuesday, Jan. 26, 2010. Carla Bruni-Sarkozy started Tuesday a two-day visit to Benin as ambassador of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

French First Lady Carla Bruni-Sarkozy, center, and Michel Kazatchkine, executive director of the U.N.-backed Global Fund to Fight AIDS, right, leave following their meeting with Benin's President Thomas Boni Yayi at the presidential palace in Cotonou, Tuesday, Jan. 26, 2010. Carla Bruni-Sarkozy started Tuesday a two-day visit to Benin as ambassador of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Benin's President Thomas Boni Yayi, right, greets French First Lady Carla Bruni-Sarkozy upon her arrival at the presidential palace in Cotonou, Tuesday, Jan. 26, 2010. Carla Bruni-Sarkozy started Tuesday a two-day visit to Benin as ambassador of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

PORT-AU-PRINCE, HAITI - JANUARY 23: A doctor checks a boy feared to have contracted malaria or meningitis in the central hospital January 23, 2010 in Port-au-Prince, Haiti. The central hospital in the capital has been overrun by patients ever since the devastating earthquake struck Haiti, and still has patients in beds outside in the courtyard and parking lot.

Andrew Witty, CEO of GlaxoSmithKline, speaks at the Council on Foreign Relations, Wednesday, Jan. 20, 2010, in New York. Drugmaker GlaxoSmithKline said Wednesday it will open up its research cupboards and labs to outside scientists in an unusual effort to trigger more research on malaria and other neglected tropical diseases. The London-based company also said its researchers expect in 2012 to be able to seek approval for the first vaccine against malaria, a mosquito-borne parasitic disease that kills a million people a year, mostly young children in Africa.

Andrew Witty, CEO of GlaxoSmithKline, speaks at the Council on Foreign Relations, Wednesday, Jan. 20, 2010, in New York. Drugmaker GlaxoSmithKline said Wednesday it will open up its research cupboards and labs to outside scientists in an unusual effort to trigger more research on malaria and other neglected tropical diseases. The London-based company also said its researchers expect in 2012 to be able to seek approval for the first vaccine against malaria, a mosquito-borne parasitic disease that kills a million people a year, mostly young children in Africa.

Andrew Witty, CEO of GlaxoSmithKline, speaks at the Council on Foreign Relations, Wednesday, Jan. 20, 2010, in New York. Drugmaker GlaxoSmithKline said Wednesday it will open up its research cupboards and labs to outside scientists in an unusual effort to trigger more research on malaria and other neglected tropical diseases. The London-based company also said its researchers expect in 2012 to be able to seek approval for the first vaccine against malaria, a mosquito-borne parasitic disease that kills a million people a year, mostly young children in Africa.

Andrew Witty, CEO of GlaxoSmithKline, speaks at the Council on Foreign Relations, Wednesday, Jan. 20, 2010, in New York. Drugmaker GlaxoSmithKline said Wednesday it will open up its research cupboards and labs to outside scientists in an unusual effort to trigger more research on malaria and other neglected tropical diseases. The London-based company also said its researchers expect in 2012 to be able to seek approval for the first vaccine against malaria, a mosquito-borne parasitic disease that kills a million people a year, mostly young children in Africa.